Arylsulfatase B (ARSB) is a lysosomal enzyme that catalyzes the hydrolysis of 4-sulfate groups from N-acetylgalactosamine residues within chondroitin-4-sulfate and dermatan sulfate. This sulfatase activity is essential for the ordered degradation of glycosaminoglycans in lysosomes. Deficiency of ARSB leads to mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome), characterized by accumulation of dermatan sulfate and chondroitin sulfate. Beyond its lysosomal role, ARSB regulates extracellular matrix composition, cell migration, and signaling pathways by controlling sulfation patterns of glycosaminoglycans.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0008484 sulfuric ester hydrolase activity | IBA GO_REF:0000033 | ACCEPT | Summary: This IBA annotation correctly identifies ARSB as a sulfuric ester hydrolase, which is accurate as ARSB catalyzes hydrolysis of sulfate ester bonds. This is the broader enzymatic class encompassing the more specific N-acetylgalactosamine-4-sulfatase activity. The phylogenetic evidence supporting this annotation is strong across mammalian orthologs. Reason: This is an appropriate molecular function term that accurately reflects the core catalytic activity of ARSB. While more general than the specific N-acetylgalactosamine-4-sulfatase activity, it correctly places ARSB in the sulfatase family. The IBA evidence based on phylogenetic conservation is robust. Supporting Evidence: PMID:2303452 Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree of similarity suggesting that they arose from a common ancestral gene and are members of an arylsulfatase gene family. file:human/ARSB/ARSB-uniprot.txt RecName: Full=Arylsulfatase B; Short=ASB; EC=3.1.6.12 file:human/ARSB/ARSB-deep-research-falcon.md See deep research file for comprehensive analysis |
| GO:0003943 N-acetylgalactosamine-4-sulfatase activity | IEA GO_REF:0000003 | ACCEPT | Summary: This annotation correctly identifies the specific enzymatic activity of ARSB. The EC mapping (EC:3.1.6.12) accurately reflects that ARSB catalyzes the hydrolysis of 4-sulfate groups from N-acetylgalactosamine residues in both chondroitin sulfate and dermatan sulfate. This is the primary and most specific molecular function of ARSB. Reason: This is the most precise molecular function term for ARSB and should be retained as a core annotation. Although this is IEA based on EC mapping, it is also supported by multiple experimental studies (IDA annotations from PMID:18285341 and PMID:19306108). Supporting Evidence: PMID:18285341 The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS. PMID:19306108 Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S). Reactome:R-HSA-1793207 Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate |
| GO:0004065 arylsulfatase activity | IEA GO_REF:0000117 | ACCEPT | Summary: This annotation identifies ARSB as having arylsulfatase activity, which is a broader classification than the specific N-acetylgalactosamine-4-sulfatase activity. While technically correct, this term is somewhat less informative than GO:0003943. Reason: This annotation is correct and reflects the arylsulfatase family membership of ARSB. Although broader than the specific sulfatase activity, it is appropriate to retain this alongside the more specific term, as it reflects the historical nomenclature and biochemical classification. This is also supported by a TAS annotation. Supporting Evidence: PMID:2303452 Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. [...] members of an arylsulfatase gene family. file:human/ARSB/ARSB-uniprot.txt RecName: Full=Arylsulfatase B |
| GO:0005764 lysosome | IEA GO_REF:0000044 | ACCEPT | Summary: This annotation correctly places ARSB in the lysosome, which is the primary and well-established cellular compartment where ARSB functions. ARSB is a classical lysosomal enzyme that degrades glycosaminoglycans in this organelle. Reason: This is a core cellular component annotation for ARSB. The lysosomal localization is extensively documented and is the primary site of ARSB function in glycosaminoglycan degradation. This is supported by both IEA and TAS evidence, as well as the original biochemical characterization of the enzyme. Supporting Evidence: PMID:2303452 The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner. file:human/ARSB/ARSB-uniprot.txt SUBCELLULAR LOCATION: Lysosome file:human/ARSB/ARSB-deep-research-perplexity-lite.md Primary: ARSB is predominantly a lysosomal enzyme |
| GO:0008484 sulfuric ester hydrolase activity | IEA GO_REF:0000120 | ACCEPT | Summary: This is a duplicate annotation of the IBA sulfuric ester hydrolase activity annotation (line 2 of GOA file), but with different evidence (IEA from combined automated methods) and ortholog mapping to rat ARSB. Reason: While this is a duplicate GO term, it represents independent evidence from automated orthology mapping, which reinforces the IBA annotation. It is acceptable to have the same term with different evidence codes. Supporting Evidence: PMID:2303452 Deduced amino acid sequences of human arylsulfatase A, human ASB, human steroid sulfatase, human glucosamine-6-sulfatase, and an arylsulfatase from sea urchin showed a substantial degree of similarity |
| GO:0009986 cell surface | IEA GO_REF:0000120 | ACCEPT | Summary: This annotation indicates ARSB localizes to the cell surface. While ARSB is primarily lysosomal, there is evidence from UniProt and literature that ARSB can be detected at the cell membrane in certain cell types, particularly in colonic and prostatic epithelial cells. This extra-lysosomal localization may have functional significance. Reason: Although ARSB is predominantly a lysosomal enzyme, the evidence for cell surface localization should not be dismissed. The deep research document notes that ARSB has been detected at cell membranes, and this may represent a non-core but biologically relevant localization. There is also an ISS annotation supporting this. Supporting Evidence: file:human/ARSB/ARSB-deep-research-perplexity-lite.md Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also detected ARSB at the cell membrane of hepatocytes, sinusoidal endothelial cells, Kupffer cells, and the apical membranes of colonic and prostatic epithelial cells. Membrane localization is reduced in malignant tissues. file:human/ARSB/ARSB-uniprot.txt SUBCELLULAR LOCATION: Lysosome. Cell surface. |
| GO:0016787 hydrolase activity | IEA GO_REF:0000043 | ACCEPT | Summary: This is a very broad molecular function term indicating that ARSB is a hydrolase, which is technically correct but not informative. This term is the parent of more specific terms like sulfuric ester hydrolase activity. Reason: While this term is extremely broad and not very informative, it is technically correct and represents the top-level enzymatic classification. It is acceptable to keep this alongside more specific terms, as it may be useful for broad queries. However, this is clearly less informative than the more specific sulfatase activity terms. Supporting Evidence: file:human/ARSB/ARSB-uniprot.txt EC=3.1.6.12 [hydrolase class] |
| GO:0046872 metal ion binding | IEA GO_REF:0000043 | MODIFY | Summary: This annotation indicates metal ion binding activity. ARSB requires calcium as a cofactor, binding one Ca2+ ion per subunit. The term is somewhat generic but is biochemically accurate. Reason: While ARSB does bind metal ions, specifically calcium, the current term is too generic. A more specific term would be calcium ion binding (GO:0005509), which accurately reflects the specific metal requirement documented in UniProt and Reactome. The current term should be replaced with the more specific calcium ion binding term. Proposed replacements: calcium ion binding Supporting Evidence: file:human/ARSB/ARSB-uniprot.txt COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Note=Binds 1 Ca(2+) ion per subunit. Reactome:R-HSA-1793207 Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate |
| GO:0006914 autophagy | IEA GO_REF:0000107 | REMOVE | Summary: This annotation suggests ARSB is involved in autophagy, based on orthology to rat ARSB. While ARSB is a lysosomal enzyme and lysosomes are involved in autophagy, there is no direct evidence that ARSB specifically participates in autophagic processes beyond being a general lysosomal enzyme. Reason: This annotation appears to be an over-annotation. While ARSB is lysosomal and lysosomes participate in autophagy, there is no specific evidence that ARSB has a direct functional role in autophagy itself. ARSB's primary function is glycosaminoglycan degradation, not autophagy regulation. This annotation likely arises from guilt-by-association with the lysosome rather than a specific biological role. Supporting Evidence: file:human/ARSB/ARSB-deep-research-perplexity-lite.md ARSB encodes the enzyme N-acetylgalactosamine-4-sulfatase, which hydrolyzes (removes) 4-sulfate groups from the GAGs dermatan sulfate and chondroitin-4-sulfate [does not mention autophagy as a specific function] |
| GO:0007584 response to nutrient | IEA GO_REF:0000107 | REMOVE | Summary: This annotation suggests ARSB is involved in response to nutrient, based on orthology to rat. There is no specific evidence that ARSB responds to or regulates nutrient sensing beyond its general role as a lysosomal enzyme. Reason: This appears to be an over-annotation without specific supporting evidence. While lysosomal function can be influenced by nutrient status, there is no indication that ARSB specifically mediates nutrient response pathways. This annotation likely reflects general lysosomal biology rather than a specific ARSB function. |
| GO:0009268 response to pH | IEA GO_REF:0000107 | REMOVE | Summary: This annotation indicates ARSB is involved in response to pH. As a lysosomal enzyme, ARSB functions optimally at acidic pH (the lysosomal environment), but there is no evidence it specifically responds to or regulates pH. Reason: This is an over-annotation. While ARSB activity is pH-dependent (like most lysosomal enzymes that function optimally at acidic pH), this does not mean ARSB is involved in pH response as a biological process. The term implies ARSB actively participates in sensing or responding to pH changes, which is not supported by evidence. |
| GO:0010976 positive regulation of neuron projection development | IEA GO_REF:0000107 | KEEP AS NON CORE | Summary: This annotation suggests ARSB positively regulates neuron projection development, based on orthology to rat. UniProt states that in the central nervous system, ARSB is a regulator of neurite outgrowth and neuronal plasticity through control of sulfate glycosaminoglycans and neurocan levels, though this is based on similarity evidence. Reason: While there is supporting evidence from UniProt (based on similarity) that ARSB regulates neurite outgrowth in the CNS, this appears to be a non-core, tissue-specific function rather than a primary function of ARSB. The core function is glycosaminoglycan degradation; the neuronal effects are downstream consequences of this activity in neural tissue. This should be retained but marked as non-core. Supporting Evidence: file:human/ARSB/ARSB-uniprot.txt In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity). file:human/ARSB/ARSB-deep-research-perplexity-lite.md Neuronal development: In the central nervous system, ARSB regulates neurite outgrowth and neuronal plasticity by controlling sulfate GAG and neurocan levels |
| GO:0043627 response to estrogen | IEA GO_REF:0000107 | REMOVE | Summary: This annotation suggests ARSB is involved in response to estrogen, based on orthology to rat. There is no specific evidence in the literature or UniProt that ARSB directly responds to or mediates estrogen signaling. Reason: This appears to be an over-annotation without supporting evidence. While ARSB expression levels might be influenced by various factors including hormones, there is no specific evidence that ARSB plays a role in estrogen response pathways. This annotation should be removed unless specific evidence emerges. |
| GO:0051597 response to methylmercury | IEA GO_REF:0000107 | REMOVE | Summary: This annotation suggests ARSB is involved in response to methylmercury, based on orthology to rat. This appears to be an artifact of expression studies in rats and does not reflect a specific biological function of ARSB. Reason: This is an over-annotation that likely reflects experimental conditions in rat studies rather than a genuine biological function. There is no evidence that ARSB has a specific role in methylmercury response or detoxification. This should be removed. |
| GO:0003943 N-acetylgalactosamine-4-sulfatase activity | IDA PMID:18285341 Distinct effects of N-acetylgalactosamine-4-sulfatase and ga... | ACCEPT | Summary: This is experimental (IDA) confirmation of the specific N-acetylgalactosamine-4-sulfatase activity of ARSB. The study directly demonstrated that ARSB hydrolyzes sulfate groups from chondroitin sulfates and that modifying ARSB expression affects chondroitin-4-sulfate levels. Reason: This is a gold-standard experimental annotation that directly demonstrates the primary molecular function of ARSB. This is core evidence supporting the specific enzymatic activity and should definitely be retained. Supporting Evidence: PMID:18285341 The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS. [...] Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly. Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly. |
| GO:0030207 chondroitin sulfate proteoglycan catabolic process | IDA PMID:18285341 Distinct effects of N-acetylgalactosamine-4-sulfatase and ga... | ACCEPT | Summary: This experimental annotation indicates ARSB is involved in chondroitin sulfate proteoglycan catabolism. The study demonstrated that ARSB expression affects the content of chondroitin sulfate and its proteoglycans, with overexpression leading to reduced CS and increased syndecan-1 and decorin core protein expression. Reason: This annotation is well-supported by experimental evidence. The study shows that ARSB affects both the glycosaminoglycan chains and the proteoglycan content, justifying annotation to the proteoglycan catabolic process. ARSB's enzymatic removal of sulfate groups from chondroitin sulfate chains is a key step in proteoglycan degradation. Supporting Evidence: PMID:18285341 Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly. Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly. PMID:18285341 mRNA expression of core proteins of the CS-containing proteoglycans, syndecan-1 and decorin, was significantly up-regulated following overexpression of ASB |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-2282889 | ACCEPT | Summary: This annotation places ARSB in the lysosomal lumen based on Reactome pathway annotation for defective ARSB in MPS VI. The lysosomal lumen is indeed where ARSB functions to degrade glycosaminoglycans. Reason: This is an accurate and specific cellular component annotation. ARSB is a soluble lysosomal enzyme that functions in the lysosomal lumen, where it encounters its substrates during glycosaminoglycan degradation. This is more specific than just "lysosome" and should be retained. Supporting Evidence: PMID:2303452 The 47-kDa ASB form was located in dense lysosomes. Reactome:R-HSA-2282889 Defective ARSB does not hydrolyse C4S/C6S chains [implies ARSB functions in lysosomal lumen] |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-9036065 | ACCEPT | Summary: This is another TAS annotation for lysosomal lumen from a different Reactome pathway (defective ARSB not hydrolyzing dermatan sulfate). This is a duplicate of the previous annotation but from a different pathway. Reason: While this is a duplicate GO term, it represents independent evidence from a different Reactome pathway, which reinforces the localization. It is acceptable to have the same term with different references. Supporting Evidence: Reactome:R-HSA-9036065 Defective ARSB does not hydrolyse DS |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-6798751 | KEEP AS NON CORE | Summary: This annotation indicates ARSB is found in the extracellular region, specifically in the context of azurophil granule exocytosis from neutrophils. ARSB can be secreted and found extracellularly. Reason: While ARSB is primarily a lysosomal enzyme, it can be secreted and found in the extracellular region, particularly during neutrophil degranulation. This represents a non-core localization that is biologically relevant but secondary to the main lysosomal function. The annotation should be retained but marked as non-core. Supporting Evidence: Reactome:R-HSA-6798751 Exocytosis of azurophil granule lumen proteins [ARSB is among the proteins released] file:human/ARSB/ARSB-deep-research-perplexity-lite.md ARSB is predominantly a lysosomal enzyme. Extra-lysosomal [localizations exist] |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-6800434 | KEEP AS NON CORE | Summary: This is another annotation for extracellular region from Reactome, this time in the context of ficolin-1-rich granule exocytosis. This is a duplicate GO term with different supporting evidence. Reason: This reinforces the extracellular localization through a different pathway (ficolin-rich granule exocytosis). As with the previous extracellular region annotation, this is a non-core localization but should be retained. Supporting Evidence: Reactome:R-HSA-6800434 Exocytosis of ficolin-rich granule lumen proteins [ARSB is among the proteins released] |
| GO:0035578 azurophil granule lumen | TAS Reactome:R-HSA-6798751 | KEEP AS NON CORE | Summary: This annotation places ARSB in azurophil granule lumen of neutrophils. Azurophil granules are specialized secretory granules in neutrophils that can contain lysosomal enzymes. Reason: This is a specialized, cell-type-specific localization of ARSB in neutrophils. While accurate, this represents a non-core localization specific to neutrophils and their degranulation processes. This should be retained as it is supported by Reactome but marked as non-core. Supporting Evidence: Reactome:R-HSA-6798751 Azurophil granules are generally described as spherical. Like lysosomes, they contain CD63 in their membrane (Cham et al. 1994) but are regarded as specialized secretory granules rather than lysosomes (Cieutat et al. 1998) |
| GO:1904813 ficolin-1-rich granule lumen | TAS Reactome:R-HSA-6800434 | KEEP AS NON CORE | Summary: This annotation places ARSB in ficolin-1-rich granule lumen, another type of secretory granule in neutrophils. This is a very specific, cell-type-restricted localization. Reason: This is an extremely specific cellular compartment in neutrophils. While the annotation is supported by Reactome, it represents a highly specialized, non-core localization. It should be retained for completeness but clearly marked as non-core and cell-type-specific. Supporting Evidence: Reactome:R-HSA-6800434 Exocytosis of ficolin-rich granule lumen proteins |
| GO:0003943 N-acetylgalactosamine-4-sulfatase activity | IDA PMID:19306108 Arylsulfatase B regulates colonic epithelial cell migration ... | ACCEPT | Summary: This is another experimental (IDA) confirmation of ARSB's N-acetylgalactosamine-4-sulfatase activity from a different study. This study demonstrated that modulating ARSB expression affects chondroitin-4-sulfate content and related cellular functions. Reason: This is independent experimental evidence for the core molecular function of ARSB. Having multiple IDA annotations from different studies strengthens the evidence for this critical activity. This should definitely be retained. Supporting Evidence: PMID:19306108 Arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase; 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from N-acetylgalactosamine 4-sulfate, which combines with glucuronate to form the disaccharide unit of chondroitin-4-sulfate (C4S). |
| GO:0009986 cell surface | ISS GO_REF:0000024 | ACCEPT | Summary: This is an ISS (Inferred from Sequence Similarity) annotation for cell surface localization, based on orthology to rat ARSB (P50430). This reinforces the IEA annotation for cell surface localization. Reason: This annotation is based on manual curation with sequence similarity to rat ARSB and represents higher quality evidence than pure IEA. Combined with the literature evidence for extra-lysosomal membrane localization of ARSB, this annotation should be retained. Supporting Evidence: file:human/ARSB/ARSB-deep-research-perplexity-lite.md Extra-lysosomal: Immunohistochemistry and immunofluorescence studies have also detected ARSB at the cell membrane of hepatocytes, sinusoidal endothelial cells, Kupffer cells, and the apical membranes of colonic and prostatic epithelial cells. file:human/ARSB/ARSB-uniprot.txt SUBCELLULAR LOCATION: Lysosome. Cell surface. |
| GO:0010632 regulation of epithelial cell migration | IMP PMID:19306108 Arylsulfatase B regulates colonic epithelial cell migration ... | ACCEPT | Summary: This experimental annotation (IMP - Inferred from Mutant Phenotype) demonstrates that ARSB regulates epithelial cell migration. The study showed that silencing or overexpressing ARSB had inverse effects on colonic epithelial cell migration. Reason: This is high-quality experimental evidence showing that ARSB regulates epithelial cell migration through its effects on chondroitin sulfate content, MMP9 expression, and RhoA activation. While this is more of a regulatory role than the core enzymatic function, it represents an important biological function of ARSB and should be retained. Supporting Evidence: PMID:19306108 When ASB expression was silenced by siRNA in the NCM460 cells, [...] cell migration increased * 52%. Following overexpression of ASB, [...] cell migration decreased * 37%. These findings demonstrate marked effects of ASB expression on the migratory activity of colonic epithelial cells file:human/ARSB/ARSB-uniprot.txt Involved in the regulation of cell adhesion, cell migration and invasion in colonic epithelium |
| GO:0010976 positive regulation of neuron projection development | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: This is an ISS annotation for positive regulation of neuron projection development, based on rat ortholog. This duplicates the IEA annotation for the same term but with manual curation evidence. Reason: This ISS annotation provides stronger evidence than the IEA annotation for the same term. As discussed previously, this represents a non-core, tissue-specific function of ARSB in the nervous system. The annotation should be retained but marked as non-core. Supporting Evidence: file:human/ARSB/ARSB-uniprot.txt In the central nervous system, is a regulator of neurite outgrowth and neuronal plasticity, acting through the control of sulfate glycosaminoglycans and neurocan levels (By similarity). |
| GO:0061580 colon epithelial cell migration | IMP PMID:19306108 Arylsulfatase B regulates colonic epithelial cell migration ... | ACCEPT | Summary: This experimental annotation (IMP) demonstrates that ARSB affects colon epithelial cell migration specifically. This is a more specific term than the general "regulation of epithelial cell migration" annotation. Reason: This is high-quality experimental evidence for a specific tissue type (colon) and represents an important biological function of ARSB. While more specific than the general epithelial cell migration term, this level of specificity is valuable and should be retained as it reflects the actual experimental system used. Supporting Evidence: PMID:19306108 In the T84 cell line, derived from lung metastasis of malignant colonic epithelial cells, [...] In the T84 cells, matrix metalloproteinase 9 (MMP9), activated RhoA, and cell migration, as well as C4S content, were significantly more than in the NCM460 cells. Silencing and overexpression of ASB had inverse effects on MMP9, activated RhoA, and cell migration |
| GO:0070062 extracellular exosome | HDA PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres... | KEEP AS NON CORE | Summary: This annotation indicates ARSB is found in extracellular exosomes, based on high-throughput detection assay (HDA) from a proteomic study of exosomes in urine. Reason: This annotation is based on proteomic detection of ARSB in exosomes. While this is a legitimate localization, it represents a non-core aspect of ARSB biology. Many proteins can be found in exosomes, and this may reflect secretion or release mechanisms rather than a primary functional localization. The annotation should be retained as it is experimentally supported, but marked as non-core. Supporting Evidence: PMID:23533145 In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine [ARSB was detected in exosomes] |
| GO:0005788 endoplasmic reticulum lumen | TAS Reactome:R-HSA-1614362 | KEEP AS NON CORE | Summary: This annotation places ARSB in the ER lumen, based on Reactome pathway for SUMF1-mediated oxidation of cysteine to formylglycine. This post-translational modification occurs in the ER during ARSB biosynthesis. Reason: This annotation reflects a transient localization during ARSB biosynthesis and maturation, not the functional localization. The formylglycine modification by SUMF1 occurs in the ER, after which ARSB is trafficked to lysosomes. This should be retained as it reflects an important aspect of ARSB biology (the post-translational modification required for activity), but marked as non-core since it is a biosynthetic intermediate. Supporting Evidence: Reactome:R-HSA-1614362 SUMF1 mediates the oxidation of cysteine to formylglycine, producing active arylsulfatases file:human/ARSB/ARSB-uniprot.txt PTM: The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of a serine or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical for catalytic activity. |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-1606789 | ACCEPT | Summary: This is another TAS annotation for lysosomal lumen from Reactome pathway "ARSB hydrolyses DS". This is a third annotation for the same GO term from a different Reactome pathway. Reason: This reinforces the lysosomal lumen localization through another Reactome pathway focused on dermatan sulfate degradation. While duplicate, multiple annotations from different pathways strengthen the evidence. Supporting Evidence: Reactome:R-HSA-1606789 Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-1793207 | ACCEPT | Summary: This is a fourth TAS annotation for lysosomal lumen from Reactome pathway "ARSB hydrolyses C4S/C6S chains". This is yet another duplicate from a different pathway. Reason: This reinforces the lysosomal lumen localization through the chondroitin sulfate degradation pathway. Multiple pathway annotations strengthen the evidence for this core localization. Supporting Evidence: Reactome:R-HSA-1793207 Arylsulfatase B using calcium cofactor (ARSB:Ca2+) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate (or 6-sulfate) units (GalNAc 4-sulfate or GalNAc 6-sulfate) within chondroitin sulfate |
| GO:0004065 arylsulfatase activity | TAS PMID:2303452 Phylogenetic conservation of arylsulfatases. cDNA cloning an... | ACCEPT | Summary: This is a TAS (Traceable Author Statement) annotation for arylsulfatase activity from the seminal 1990 paper that cloned and characterized human ARSB. This provides experimental literature support for the arylsulfatase classification. Reason: This is a foundational reference for ARSB characterization and provides strong experimental support for the arylsulfatase activity annotation. This should definitely be retained as it represents the original biochemical characterization of the enzyme. Supporting Evidence: PMID:2303452 Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. [...] Overexpression of ASB in transfected baby hamster kidney (BHK) cells resulted in up to 68-fold higher ASB activity |
| GO:0005764 lysosome | TAS PMID:2303452 Phylogenetic conservation of arylsulfatases. cDNA cloning an... | ACCEPT | Summary: This is a TAS annotation for lysosome localization from the same foundational 1990 paper. This provides experimental literature support for the lysosomal localization. Reason: This is strong experimental evidence from the original characterization of ARSB showing its lysosomal localization and mannose-6-phosphate receptor-mediated trafficking. This is core evidence that should definitely be retained. Supporting Evidence: PMID:2303452 The 47-kDa ASB form was located in dense lysosomes. Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner. |
| GO:0007040 lysosome organization | TAS PMID:1718978 Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An inter... | REMOVE | Summary: This annotation suggests ARSB is involved in lysosome organization. The reference is to a 1991 paper about MPS VI mutations, which describes the disease phenotype but does not directly demonstrate that ARSB organizes lysosomes. Reason: This appears to be a misannotation. While ARSB deficiency leads to lysosomal storage disease (MPS VI), this does not mean ARSB's primary function is to organize lysosomes. ARSB is a lysosomal enzyme that degrades glycosaminoglycans; its absence causes substrate accumulation and lysosomal dysfunction, but this is a consequence of enzyme deficiency, not evidence that ARSB actively organizes lysosomes. This annotation should be removed. Supporting Evidence: PMID:1718978 The Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI) is a lysosomal storage disease with autosomal recessive inheritance caused by deficiency of the enzyme arylsulfatase B |
| GO:0007041 lysosomal transport | TAS PMID:2303452 Phylogenetic conservation of arylsulfatases. cDNA cloning an... | REMOVE | Summary: This annotation suggests ARSB is involved in lysosomal transport. The reference describes ARSB being transported TO lysosomes via the mannose-6-phosphate receptor pathway, not that ARSB performs transport functions. Reason: This is a misannotation. The reference describes ARSB as a cargo being transported to lysosomes, not as performing transport functions. ARSB is a lysosomal enzyme that degrades substrates; it does not transport materials. This annotation confuses the trafficking of ARSB to lysosomes with ARSB having a transport function. This should be removed. Supporting Evidence: PMID:2303452 Transport of ASB to the lysosomes was accomplished in a mannose 6-phosphate receptor-dependent manner |
| GO:0030209 dermatan sulfate proteoglycan catabolic process | TAS Reactome:R-HSA-1606789 | NEW | Summary: ARSB is directly involved in dermatan sulfate degradation by removing 4-sulfate groups from N-acetylgalactosamine-4-sulfate residues. This is one of the primary catabolic pathways in which ARSB participates, as documented in Reactome and the cyberian deep research. Reason: This biological process annotation is missing from the existing GOA file but is a core function of ARSB. Dermatan sulfate is one of two primary substrates for ARSB, and its degradation is blocked in MPS VI patients. This annotation is well-supported by Reactome pathway documentation and literature. Supporting Evidence: Reactome:R-HSA-1606789 Arylsulfatase B (ARSB) hydrolyses sulfate from N-acetylgalactosamine 4-sulfate units within dermatan sulfate (DS; Gorham & Cantz 1978) file:human/ARSB/ARSB-deep-research-cyberian.md ARSB acts specifically on two major sulfated glycosaminoglycans: Dermatan sulfate (DS): A heteropolysaccharide composed of repeating disaccharide units containing iduronic acid and N-acetylgalactosamine-4-sulfate file:human/ARSB/ARSB-uniprot.txt Hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. |
| GO:0006027 glycosaminoglycan catabolic process | TAS Reactome:R-HSA-1606789 | NEW | Summary: ARSB participates in the broader glycosaminoglycan catabolic process through its specific role in degrading dermatan sulfate and chondroitin-4-sulfate. This is the parent process that encompasses the more specific DS and C4S catabolic activities. Reason: This biological process annotation represents the broader catabolic category encompassing ARSB function. While more general than the specific dermatan sulfate or chondroitin sulfate proteoglycan catabolic processes, it appropriately captures ARSB's role in GAG catabolism. The annotation is supported by Reactome pathway documentation and literature. Supporting Evidence: Reactome:R-HSA-1606789 Defects in ARSB are the cause of mucopolysaccharidosis type VI (MPSVI) (MIM:253200, also called Maroteaux-Lamy syndrome file:human/ARSB/ARSB-deep-research-cyberian.md ARSB functions within the lysosomal catabolism pathway for sulfated glycosaminoglycans. The sequential degradation of dermatan sulfate and chondroitin sulfate requires multiple enzymes acting in a specific order. file:human/ARSB/ARSB-uniprot.txt DISEASE: Mucopolysaccharidosis 6 (MPS6) [MIM:253200]: A form of mucopolysaccharidosis, a group of lysosomal storage diseases characterized by defective degradation of glycosaminoglycans |
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)